{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:07:00Z","timestamp":1789456020469,"version":"build-2803163510"},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA164047"],"award-info":[{"award-number":["K08CA164047"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA142543"],"award-info":[{"award-number":["5P30CA142543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Propath"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Alterations in pathways including\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      ,\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      <\/jats:italic>\n                      , and\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">TERT<\/jats:styled-content>\n                      <\/jats:italic>\n                      contribute to the development of melanoma, but the sequence in which the genetic alterations occur and their prognostic significance remains unclear. To clarify the role of these pathways, we analyzed a primary melanoma and its metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Immunohistochemistry for\n                      <jats:styled-content style=\"fixed-case\">BRAF\u2010V600E<\/jats:styled-content>\n                      , Sanger sequencing of\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      and the\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">TERT<\/jats:styled-content>\n                      <\/jats:italic>\n                      promoter, fluorescence\n                      <jats:italic>in\u2010situ<\/jats:italic>\n                      hybridization, and telomere analyses were performed on a primary melanoma and its asynchronous cerebellar metastasis. Using the log\u2010rank test and Cox\u2010proportional model, the cancer genome atlas (\n                      <jats:styled-content style=\"fixed-case\">TCGA<\/jats:styled-content>\n                      ) cohort of melanomas was analyzed for the effect of\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      mutation and\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      <\/jats:italic>\n                      loss on survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The primary melanoma expressed mutant\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">V600E<\/jats:styled-content>\n                      and possessed a homozygous deletion of\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      <\/jats:italic>\n                      . In addition to these early defects, the metastatic lesion also possessed evidence of aneuploidy and an activating mutation of the\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">TERT<\/jats:styled-content>\n                      <\/jats:italic>\n                      promoter. In the\n                      <jats:styled-content style=\"fixed-case\">TCGA<\/jats:styled-content>\n                      melanoma cohort, there was a non\u2010significant trend toward poor prognosis in early stage cutaneous melanoma patients with concomitant\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      mutation and\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      <\/jats:italic>\n                      loss.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\n                      <\/jats:italic>\n                      mutation and\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      <\/jats:italic>\n                      loss occurred early and\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">TERT<\/jats:styled-content>\n                      <\/jats:italic>\n                      promoter mutation later in a case of lethal metastatic melanoma. The effects of these pathways on survival warrant further investigation in early stage cutaneous melanoma patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cup.12444","type":"journal-article","created":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T04:39:11Z","timestamp":1416371951000},"page":"108-117","source":"Crossref","is-referenced-by-count":14,"title":["A primary melanoma and its asynchronous metastasis highlight the role of\n                    <i>\n                      <scp>BRAF<\/scp>\n                    <\/i>\n                    ,\n                    <i>\n                      <scp>CDKN2A<\/scp>\n                    <\/i>\n                    , and\n                    <scp>\n                      <i>TERT<\/i>\n                    <\/scp>"],"prefix":"10.1111","volume":"42","author":[{"given":"Gregory A.","family":"Hosler","sequence":"first","affiliation":[{"name":"Department of Dermatology UT Southwestern Medical Center  Dallas TX USA"},{"name":"ProPath  Dallas TX USA"},{"name":"Department of Pathology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Davoli","sequence":"additional","affiliation":[{"name":"Division of Genetics Brigham and Women's Hospital  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilgen","family":"Mender","sequence":"additional","affiliation":[{"name":"Department of Cell Biology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Litzner","sequence":"additional","affiliation":[{"name":"Department of Dermatology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyuk","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Yale Medical School  New Haven CT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[{"name":"Department of Pathology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry W.","family":"Shay","sequence":"additional","affiliation":[{"name":"Department of Cell Biology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology UT Southwestern Medical Center  Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000160"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800653"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182498be5"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1054"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt119"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104658"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-091212-153429"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20753"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182753de6"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1731"},{"key":"e_1_2_5_12_1","first-page":"1968","article-title":"Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin","volume":"60","author":"Bastian BC","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229259"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4401"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju246"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1309\/R494HQ9VRDJWDY30"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2323"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1195-5"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.132"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.2452"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.4265"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.910"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12133"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31824b1efd"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(03)00542-6"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23674.x"},{"key":"e_1_2_5_27_1","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki\u201067) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume O","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4327"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00837.x"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.064"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2947"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2941"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.238"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1988"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E13-10-0564"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e13-08-0479"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt775"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.04.044"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2245"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.03.044"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-092910-154234"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e3181b72d6f"},{"key":"e_1_2_5_43_1","first-page":"707","article-title":"High frequency of tetraploidy detected in malignant melanoma of Japanese patients by fluorescence in situ hybridization","volume":"17","author":"Satoh S","year":"2000","journal-title":"Int J Oncol"},{"key":"e_1_2_5_44_1","first-page":"702","article-title":"Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?","volume":"108","author":"Gattuso P","year":"1990","journal-title":"Surgery"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199604000-00006"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12470449"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198804000-00014"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1219580"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.10.011"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2011.10.001"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1667\/0033-7587(2001)155[0188:TATIFC]2.0.CO;2"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0506"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(99)00047-7"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcup.12444","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cup.12444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:04:46Z","timestamp":1696349086000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cup.12444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/cup.12444"],"URL":"https:\/\/doi.org\/10.1111\/cup.12444","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}